Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | CRHBP | P24387 | 2/20 | 0.50 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.50 |
| ▸ | KCNQ2 | O43526 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | KDM4A | O75164 | 1/20 | 0.49 |
| ▸ | BCHE | P06276 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fenbutyramide SCHEMBL1478462 | 1.00 | EPHX1 (0.63) | EPHX1LMNAHSD17B10ALDH1A1POLB | |
| Fenbutyramide SCHEMBL1477997 | 1.00 | EPHX1 (0.63) | EPHX1LMNAHSD17B10ALDH1A1POLB | |
| Fenbutyramide SCHEMBL15995561 | 0.98 | EPHX1 (0.61) | EPHX1LMNAHSD17B10ALDH1A1POLB | |
| SCHEMBL4935067 | 0.85 | LMNA (0.61) | LMNAHSD17B10ALDH1A1POLBCRHBP | |
| SCHEMBL15828137 | 0.84 | LMNA (0.53) | EPHX1LMNAHSD17B10ALDH1A1POLB | |
| SCHEMBL2183709 | 0.84 | EPHX1 (0.59) | EPHX1LMNAHSD17B10KCNQ2SMN1; SMN2 | |
| SCHEMBL18098100 | 0.83 | EPHX1 (0.54) | EPHX1LMNAHSD17B10ALDH1A1POLB | |
| SCHEMBL1715 | 0.83 | LMNA (0.59) | LMNAHSD17B10ALDH1A1POLBCRHBP | |
| SCHEMBL65737 | 0.83 | LMNA (0.59) | LMNAHSD17B10ALDH1A1POLBCRHBP | |
| SCHEMBL20769804 | 0.83 | LMNA (0.59) | LMNAHSD17B10ALDH1A1POLBCRHBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1027 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12383624-B2 | Cargo delivery system and composition comprising the same | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2025-08-12 | — | — | US | claimed |
| WO-2025101731-A1 | SGLT1 INHIBITORS FOR USE IN THE TREATMENT OF HEPATIC ENCEPHALOPATHY | LEXICON PHARMACEUTICALS, INC. (US) | 2025-05-15 | — | — | WO | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| CN-115745828-A | Method for producing phenylamide | 山东新华制药股份有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115403761-A | Polyglycol modified lipid compound and preparation method and application thereof | 天津键凯科技有限公司 | 2022-11-29 | — | — | CN | claimed |
| CN-114149337-B | Novel ionizable lipid for nucleic acid delivery and LNP composition thereof | 天津键凯科技有限公司 | 2022-04-29 | — | — | CN | claimed |
| CN-109851519-A | A method of 2- phenylbutanamides are isolated and purified from phenobarbital production waste residue | 山东新华制药股份有限公司 | 2019-06-07 | — | — | CN | claimed |
| CN-109734619-A | A method of impurity A, C are isolated and purified from phenobarbital production waste residue | 山东新华制药股份有限公司 | 2019-05-10 | — | — | CN | claimed |
| CN-108699106-A | Novel trifluoromethyl propanamide derivative as HTRA1 inhibitor | 豪夫迈·罗氏有限公司 | 2018-10-23 | — | — | CN | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | claimed |
| WO-2004018461-A2 | ANTIBACTERIAL BENZOIC ACID DERIVATIVES | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-03-04 | — | — | WO | claimed |
| WO-2004018428-A1 | ANTIBACTERIAL BENZOIC ACID DERIVATIVES | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-03-04 | — | — | WO | claimed |
| US-6365186-B1 | ADMINISTERING TO PATIENT UNSUBSTITUTED POLYDIALLYLAMINE POLYMER AND CHOLESTEROL-LOWERING AGENT IN THERAPEUTICALLY EFFECTIVE AMOUNT | GELTEX PHARMACEUTICALS, INC. | 2002-04-02 | — | — | US | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000069445-A1 | COMBINATION THERAPY FOR TREATING HYPERCHOLESTEROLEMIA | GELTEX PHARMACEUTICALS, INC. (US) | 2000-11-23 | — | — | WO | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| US-5783605-A | Helper inducers for differentiation therapy and chemoprevention of cancer | KUO SHENG-CHU (TW) | 1998-07-21 | — | — | US | claimed |
| EP-0298758-B1 | Hydroquinonylphenyl butyric acid amide derivative | SUNTORY LTD (JP) | 1995-06-28 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12383624-B2 | Cargo delivery system and composition comprising the same | ATG7, SQSTM1, BECN1 | EPHX1 4333/4885LMNA 1430/4885HSD17B10 4388/4885 |
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | EPHX1 1803/4885LMNA 3376/4885HSD17B10 2592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.